Ebola Treatments Could Be Orphan Candidates – But Vaccines, Probably Not
Executive Summary
FDA expects few people would get the disease in the U.S., but many could receive a vaccine.
You may also be interested in...
Ebola Vaccines: FDA Advisory Committee Convenes As Outbreak Recedes
Challenge of testing vaccines when infections seem to be coming under control is among potential issues for May 12 meeting.
Modest Increase To 2015 FDA Funds Includes $903.4 Mil. For CFSAN
An omnibus spending agreement gives FDA about a 1.3% increase from its fiscal 2014 appropriation. CFSAN’s allocation of $903.4 million represents a more than 2% increase over fiscal 2014 enacted funding, consistent with the President’s budget request and the Senate’s proposed funding, but roughly $10 million less than the original House figure.
FDA Gets Senate Funding, House Scolding In Fiscal 2015 Appropriation
An omnibus spending agreement gives FDA about a 1.3% increase from its fiscal 2014 appropriation. But the Office of the Commissioner still stands to lose $20 million if FDA does not finalize draft guidance on evaluation and labeling of abuse-deterrent opioids by June 30, 2015.